Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis
Fatemeh Hadi, Shayan Kashefinejad, Leila Kamalzadeh, et al.
BMC Pharmacology and Toxicology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Exploring the serotonin‐probiotics‐gut health axis: A review of current evidence and potential mechanisms
Noor Akram, Zargham Faisal, Rushba Irfan, et al.
Food Science & Nutrition (2023) Vol. 12, Iss. 2, pp. 694-706
Open Access | Times Cited: 38
Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis
Bruna Panizzutti, David Skvarc, Sylvia Chu Lin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5250-5250
Open Access | Times Cited: 30
N-acetylcysteine: An Innovative Approach to Obsessive-Compulsive Disorder Treatment: A Narrative Review
Sadia Binte Anwar Sonia, Muhammad Nurul Alam Siddiki, Sarmin Sultana, et al.
Advances in Human Biology (2025)
Open Access | Times Cited: 1
The Potential of N-Acetylcysteine for Treatment of Trichotillomania, Excoriation Disorder, Onychophagia, and Onychotillomania: An Updated Literature Review
Debra Lee, Shari R. Lipner
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 11, pp. 6370-6370
Open Access | Times Cited: 25
Tourette syndrome and obsessive-compulsive disorder: A comprehensive review of structural alterations and neurological mechanisms
Anna D. Shitova, Tatyana S. Zharikova, Ольга Николаевна Ковалева, et al.
Behavioural Brain Research (2023) Vol. 453, pp. 114606-114606
Closed Access | Times Cited: 12
Glutamatergic Medications for Obsessive-Compulsive and Related Disorders
David Richer Araujo Coelho, Chen Yang, Armiel Suriaga, et al.
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2452963-e2452963
Closed Access
Editorial: Safety and side effects of psychotropic medications, volume III
Renato de Filippis, Mireia Solerdelcoll, Mohammadreza Shalbafan
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive–compulsive disorder: a systematic review and meta-analysis of randomized clinical trials
Negin Eissazade, Hesam Mosavari, Shayan Eghdami, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Clinical Advances in Treatment Strategies for Obsessive-compulsive Disorder in Adults
Daeyoung Roh, Ki-Won Jang, Chan‐Hyung Kim
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 4, pp. 676-685
Open Access | Times Cited: 7
The promise of N‐acetylcysteine in the treatment of obsessive‐compulsive disorder
Massimo Carollo, Nicola Carollo, Giulia Montan
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 2
Towards zebrafish models to unravel translational insights of obsessive-compulsive disorder: A neurobehavioral perspective
João V. Borba, Júlia Canzian, Cássio M. Resmim, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105715-105715
Closed Access | Times Cited: 2
Cognitive Rehabilitation for Adult Patients With Obsessive-compulsive Disorder: A Systematic Review of Randomized Controlled Trials
Farah Bakizadeh, Saba Mokhtari, Fahime Saeed, et al.
Basic and Clinical Neuroscience Journal (2024) Vol. 15, Iss. 3, pp. 287-300
Open Access | Times Cited: 2
Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive–compulsive disorder: A network meta‐analysis
Rituparna Maiti, Archana Mishra, Anand Srinivasan, et al.
Acta Psychiatrica Scandinavica (2023) Vol. 148, Iss. 1, pp. 19-31
Closed Access | Times Cited: 5
Acute administration of the NMDA receptor antagonists ketamine and MK-801 reveals dysregulation of glutamatergic signalling and sensorimotor gating in the Sapap3 knockout mouse model of compulsive-like behaviour
James J Gattuso, Carey Wilson, Anthony J. Hannan, et al.
Neuropharmacology (2023) Vol. 239, pp. 109689-109689
Closed Access | Times Cited: 5
Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial
Marjan Shokrani, Sanaz Askari, Negin Eissazade, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
The safety and efficacy of N-acetylcysteine as an augmentation in the treatment of obsessive-compulsive disorder in adults: a systematic review and meta-analysis of randomized clinical trials
Shayan Eghdami, Negin Eissazade, Mohsen Heidari Mokarar, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial
Ala Ghobadian, Saba Mokhtari, Behnam Shariati, et al.
BMC Pharmacology and Toxicology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial
Marjan Shokrani, Sanaz Askari, Negin Eissazade, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Navegando pelas obsessões e compulsões: estratégias para o manejo do TOC e melhoria da qualidade de vida dos pacientes
I. Gomes, Camila Agostinis Silva, Cláudia Marques Andrade Franco, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 1, pp. 1225-1235
Open Access
Role of Glutamatergic Modulators in the Treatment of Obsessive Compulsive and Related Disorders
Fatma Gül Helvacı Çelik, Çiçek Hocaoğlu
Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry (2024) Vol. 16, Iss. 3, pp. 383-400
Open Access
Efficacy of topiramate in treating obsessive compulsive disorder: A systematic review and meta-analysis
Pietro Carmellini, Alessandro Cuomo, Andrea Fagiolini
Journal of Affective Disorders Reports (2024) Vol. 17, pp. 100787-100787
Open Access
Correlation between compulsive behaviors and plastic changes in the dendritic spines of the prefrontal cortex and dorsolateral striatum of male rats
Marisela Hernández‐González, Jahaziel de la Torre-Vázquez, Francisco Javier Barrera-Cobos, et al.
Behavioural Brain Research (2024) Vol. 475, pp. 115199-115199
Closed Access
Prospects for using N-acetylcysteine in the treatment of obsessive-compulsive disorder
А. N. Useinova, E.Yu. Vetrova, N. A. IZETOVA, et al.
Hirurg (Surgeon) (2024), Iss. 3, pp. 49-56
Closed Access
The Effect of Add-on Memantine in New Onset Combat-Related Posttraumatic Stress Disorder Core Symptoms: A Pilot Study
Fatemeh Rajabi, Fatemeh Fozveh, Mohammad Reza Maracy
Iranian Journal of Psychiatry (2023)
Open Access | Times Cited: 1
Editorial: Biological and non-pharmacological treatments of obsessive-compulsive disorder and related disorders
Renato de Filippis, Samer El Hayek, Mohammadreza Shalbafan
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top